Home » Topics » BioWorld Science

BioWorld Science
RSS

ReViral presents RSV fusion inhibitors as new antivirals

Feb. 7, 2019

Sichuan Haisco Pharmaceutical describes kappa-opioid receptor agonists

Feb. 7, 2019

Evotec and Galapagos collaborate on small-molecule fibrotic disease program

Feb. 7, 2019

ProtNeteomix identifies new EGFR degradation inducers

Feb. 7, 2019

U.S. researchers present new compounds for tuberculosis

Feb. 7, 2019

Inhibrx begins first-in-human study of INBRX-105 bispecific antibody for cancer

Feb. 7, 2019

FDA approves Cablivi for treatment of aTTP

Feb. 7, 2019

Early cardiac hypertrophy seen in murine model of Pompe disease

Feb. 7, 2019

Updated clinical data presented from ongoing studies of AVR-RD-01 gene therapy for Fabry disease

Feb. 7, 2019

Positive results announced from phase I study of LY-3056480 in sensorineural hearing loss

Feb. 7, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 21, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
New biomarker may improve RSV drug screening
BioWorld
Respiratory syncytial virus (RSV) infection is responsible for 3.2 million hospital admissions and about 118,000 deaths in children under 5 years of age. The...